Expression of a constitutively active SRC mutant (SRCY527F) promoted YAP/TAZ transcriptional activity in the majority of the cell lines we tested, including several human and mouse breast cancer and melanoma cell lines (Fig. 1B). This evidence concerns the gene SRC and melanoma.